The American Society for 
Automation in Pharmacy (ASAP) has added functionality to its pseudoephedrine (PSE)-tracking standard that allows a retailer to query a PSE database prior to a sale, without having to provide product detail, to determine whether a person has reached his or her quantity limit.

The new version (V1.1) also allows the acknowledgment when a sale is blocked that the product was in fact not sold. This functionality has been added in the event states decide to require that this information be reported.

The organization responded to a request from Appriss, which handles the PSE-tracking systems for a number of states, to add the new feature in order to accommodate inquiries before the sale by swiping a person’s driver’s license to determine quantity limit and then reporting this information to the states via the ASAP format.